Although there have been in vitro studies that demonstrate the role of DUOX2 in carcinogenesis [30], tumor progression [18], and chemotherapeutic resistance [19], particularly in colorectal and pancreatic adenocarcinoma, the association between DUOX2 and CCRT response has rarely been reported. The gene discussed is DUOX2; the disease is pancreatic adenocarcinoma.